Western medicine composition for treating liver cancer

A technology for the treatment of liver cancer and compositions, applied in the directions of drug combinations, active ingredients of heterocyclic compounds, anti-tumor drugs, etc., can solve the problems of immune function suppression, physical damage of patients, killing of normal cells, etc., achieve stable properties, reduce side effects, The effect of promoting drug metabolism

Inactive Publication Date: 2016-07-06
QINGDAO HUANGDAO HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Modern medicine mainly uses surgery, radiotherapy and chemotherapy for the treatment of liver cancer, but these methods have defects. Only early patients can undergo surgical treatment. Surgical treatment is a means of local treatment. It has no effect. Radiotherapy and chemotherapy can effectively injure cancer cells, but at the same time it can kill normal cells, resulting in the suppression of the patient's immune function, more complications, and great damage to the patient's body.
However, the traditional oral drugs for the treatment of liver cancer also have the problems of large side effects and ineffective curative effect, which have certain limitations.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] A western medicine composition for treating liver cancer, which consists of the following components: norcantharidin 3.9mg, chlorooxyquine 80.2mg, mannan peptide 6.3mg, hydrous lactose 4.8mg, magnesium stearate 2.7mg, microcrystalline fiber Cantharidin 3.1mg, pregelatinized starch 4.0mg, starch 15.0mg, wherein, norcantharidin, chloroxyquine, mannan peptide are drug components.

Embodiment 2

[0022] A western medicine composition for treating liver cancer, which consists of the following components: norcantharidin 3.2mg, chlorooxyquine 89.3mg, mannan peptide 3.4mg, hydrous lactose 5.2mg, magnesium stearate 2.5mg, microcrystalline fiber Cantharidin 4.2mg, pregelatinized starch 3.7mg, starch 8.5mg, wherein, norcantharidin, chloroxyquine, mannan peptide are drug components.

Embodiment 3

[0024] A western medicine composition for treating liver cancer, which consists of the following components: norcantharidin 4.8mg, chlorooxyquine 75.5mg, mannan peptide 8.6mg, hydrous lactose 3.4mg, magnesium stearate 3.6mg, microcrystalline fiber Cantharidin 2.8mg, pregelatinized starch 4.6mg, starch 16.7mg, wherein, norcantharidin, chloroxyquine, mannan peptide are drug components.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of a medicine, and in particular relates to a Western medicine composition for treating liver cancer. The Western medicine composition consists of the following components: 3.2-4.8mg of norcantharidin, 75.5-89.3mg of chloroxoquinoline, 3.4-8.6mg of mannatide, 3.4-5.2mg of lactose hydrous, 2.5-3.6mg of magnesium stearate, 2.8-4.2mg of microcrystalline cellulose, 3.7-4.6mg of pregelatinized starch and the balance starch, wherein the total amount of the above components is 120mg, wherein the norcantharidin, the chloroxoquinoline and the mannatide are pharmaceutical ingredients. By virtue of a preparation method, tablets, each of which is 120mg, are prepared. The medicine disclosed by the invention has the characteristics of being convenient to use, short in treatment course, significant in curative effects and low in side effects.

Description

technical field [0001] The invention belongs to the technical field of medicines, in particular to a western medicine composition for treating liver cancer. Background technique [0002] Liver cancer is a malignant tumor of the liver. It is a common and frequently-occurring disease in surgical diseases. Liver cancer can be divided into two categories: primary and secondary. Primary malignant tumors of the liver originate from the epithelial or mesenchymal tissues of the liver. The former is called primary liver cancer, which is a malignant tumor with a high incidence in my country and is extremely harmful; rare. Secondary or metastatic liver cancer refers to the invasion of liver by malignant tumors originating from multiple organs throughout the body, and is generally seen in liver metastases of malignant tumors in stomach, biliary tract, pancreas, colorectum, ovary, uterus, lung, breast, and other organs. [0003] Since the liver is the largest substantial organ of the hu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/16A61P35/00A61K31/47A61K31/34
Inventor 卢彦敏
Owner QINGDAO HUANGDAO HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products